383 related articles for article (PubMed ID: 18855822)
1. A randomized clinical trial of methadone maintenance for prisoners: findings at 6 months post-release.
Gordon MS; Kinlock TW; Schwartz RP; O'Grady KE
Addiction; 2008 Aug; 103(8):1333-42. PubMed ID: 18855822
[TBL] [Abstract][Full Text] [Related]
2. A randomized clinical trial of methadone maintenance for prisoners: results at 1-month post-release.
Kinlock TW; Gordon MS; Schwartz RP; O'Grady K; Fitzgerald TT; Wilson M
Drug Alcohol Depend; 2007 Dec; 91(2-3):220-7. PubMed ID: 17628351
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of methadone maintenance for prisoners: results at 12 months postrelease.
Kinlock TW; Gordon MS; Schwartz RP; Fitzgerald TT; O'Grady KE
J Subst Abuse Treat; 2009 Oct; 37(3):277-85. PubMed ID: 19339140
[TBL] [Abstract][Full Text] [Related]
4. A randomized controlled trial of interim methadone maintenance.
Schwartz RP; Highfield DA; Jaffe JH; Brady JV; Butler CB; Rouse CO; Callaman JM; O'Grady KE; Battjes RJ
Arch Gen Psychiatry; 2006 Jan; 63(1):102-9. PubMed ID: 16389204
[TBL] [Abstract][Full Text] [Related]
5. Methadone maintenance in prison: evaluation of a pilot program in Puerto Rico.
Heimer R; Catania H; Newman RG; Zambrano J; Brunet A; Ortiz AM
Drug Alcohol Depend; 2006 Jun; 83(2):122-9. PubMed ID: 16332415
[TBL] [Abstract][Full Text] [Related]
6. Methadone continuation versus forced withdrawal on incarceration in a combined US prison and jail: a randomised, open-label trial.
Rich JD; McKenzie M; Larney S; Wong JB; Tran L; Clarke J; Noska A; Reddy M; Zaller N
Lancet; 2015 Jul; 386(9991):350-9. PubMed ID: 26028120
[TBL] [Abstract][Full Text] [Related]
7. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
[TBL] [Abstract][Full Text] [Related]
8. Four-year follow-up of imprisoned male heroin users and methadone treatment: mortality, re-incarceration and hepatitis C infection.
Dolan KA; Shearer J; White B; Zhou J; Kaldor J; Wodak AD
Addiction; 2005 Jun; 100(6):820-8. PubMed ID: 15918812
[TBL] [Abstract][Full Text] [Related]
9. Intravenous and intranasal heroin-dependent treatment-seekers: characteristics and treatment outcome.
Highfield DA; Schwartz RP; Jaffe JH; O'Grady KE
Addiction; 2007 Nov; 102(11):1816-23. PubMed ID: 17784892
[TBL] [Abstract][Full Text] [Related]
10. A randomized controlled trial of prison-initiated buprenorphine: prison outcomes and community treatment entry.
Gordon MS; Kinlock TW; Schwartz RP; Fitzgerald TT; O'Grady KE; Vocci FJ
Drug Alcohol Depend; 2014 Sep; 142():33-40. PubMed ID: 24962326
[TBL] [Abstract][Full Text] [Related]
11. Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners.
Wilson ME; Kinlock TW; Gordon MS; O'Grady KE; Schwartz RP
Am J Addict; 2012; 21(5):476-87. PubMed ID: 22882399
[TBL] [Abstract][Full Text] [Related]
12. A novel opioid maintenance program for prisoners: report of post-release outcomes.
Kinlock TW; Battjes RJ; Schwartz RP;
Am J Drug Alcohol Abuse; 2005; 31(3):433-54. PubMed ID: 16161728
[TBL] [Abstract][Full Text] [Related]
13. Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12-month findings.
Schwartz RP; Kelly SM; O'Grady KE; Gandhi D; Jaffe JH
Addiction; 2012 May; 107(5):943-52. PubMed ID: 22029398
[TBL] [Abstract][Full Text] [Related]
14. A randomised controlled trial of methadone maintenance treatment versus wait list control in an Australian prison system.
Dolan KA; Shearer J; MacDonald M; Mattick RP; Hall W; Wodak AD
Drug Alcohol Depend; 2003 Oct; 72(1):59-65. PubMed ID: 14563543
[TBL] [Abstract][Full Text] [Related]
15. A randomized controlled trial of interim methadone maintenance: 10-Month follow-up.
Schwartz RP; Jaffe JH; Highfield DA; Callaman JM; O'Grady KE
Drug Alcohol Depend; 2007 Jan; 86(1):30-6. PubMed ID: 16793221
[TBL] [Abstract][Full Text] [Related]
16. Drug use and injection risk-taking among prison methadone maintenance patients.
Darke S; Kaye S; Finlay-Jones R
Addiction; 1998 Aug; 93(8):1169-75. PubMed ID: 9813898
[TBL] [Abstract][Full Text] [Related]
17. Heroin Use, HIV-Risk, and Criminal Behavior in Baltimore: Findings from Clinical Research.
Schwartz RP; Kelly SM; Gryczynski J; Mitchell SG; O'Grady KE; Jaffe JH
J Addict Dis; 2015; 34(2-3):151-61. PubMed ID: 26079104
[TBL] [Abstract][Full Text] [Related]
18. Methadone dose at the time of release from prison significantly influences retention in treatment: implications from a pilot study of HIV-infected prisoners transitioning to the community in Malaysia.
Wickersham JA; Zahari MM; Azar MM; Kamarulzaman A; Altice FL
Drug Alcohol Depend; 2013 Sep; 132(1-2):378-82. PubMed ID: 23414931
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification.
Gruber VA; Delucchi KL; Kielstein A; Batki SL
Drug Alcohol Depend; 2008 Apr; 94(1-3):199-206. PubMed ID: 18243585
[TBL] [Abstract][Full Text] [Related]
20. The Key Extended Entry Program (KEEP): from the community side of the bridge.
Fallon BM
Mt Sinai J Med; 2001 Jan; 68(1):21-7. PubMed ID: 11135502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
